Skip to content
PubMed This is a summary of 4 peer-reviewed journal articles Updated
Neurology

Tracking the Journey: Symptoms and Progression of FENIB

At a Glance

FENIB is a rare inherited brain disorder whose symptoms and timing vary by SERPINI1 variant. It may begin with behavior or thinking changes, followed by myoclonus, seizures, movement problems, and increasing need for daily support; early planning helps protect comfort and safety.

Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB) is a progressive condition, meaning symptoms tend to appear and worsen over time. Because it is so rare—with only about 13 cases documented in medical literature reviews—the “typical” timeline is based on a very small group of people [1]. However, researchers have identified reported patterns in how the disease affects behavior, movement, and cognitive health.

The Genotype-Phenotype Connection

One of the most important things to understand about FENIB is that the specific mutation (the genotype) often influences how early and how severely the symptoms (the phenotype) appear [2].

The disease is caused by the neuroserpin protein becoming unstable and clumping together. Scientists have found that the more “unstable” the protein is, the earlier the symptoms tend to start [2]. For example:

  • Early Onset: Variations like G392E cause the protein to clump very rapidly. This has been reported in symptoms starting in childhood or adolescence (as early as age 11) and a more rapid decline [1].
  • Later Onset: Variations like S49P are slightly more stable, reported in some patients whose symptoms do not appear until adulthood [1].

Across a small review of 13 documented cases, the median age of onset was approximately 21 years, and the median age of death was approximately 33 years [1]. However, these are just midpoints from a tiny, highly selected cohort; individual experiences vary widely based on the specific genetic “variant” your family carries, and these numbers do not predict an individual’s personal course.

Early Warning Signs: Behavioral Changes

While many people associate FENIB with seizures, the very first signs are reported in some patients to be subtle behavioral or mental changes. These can appear years before any physical muscle jerks are noticed, though seizure or movement symptoms may come first for others [3].

  • Inattention and Executive Dysfunction: A person may struggle to focus, organize tasks, or follow complex conversations [3].
  • Social Disinhibition: This refers to a loss of the “social filter.” A loved one might act impulsively, make inappropriate comments, or show a change in personality that seems out of character [3].
  • Cognitive Decline: This is a progressive loss of thinking skills. Early FENIB cognitive decline often involves executive problems and a struggle with judgment and planning [1].

The Core Syndrome: Epilepsy and Movement

As the disease progresses, physical symptoms become more prominent. The hallmark of FENIB is Progressive Myoclonic Epilepsy (PME) [1].

  • Myoclonus: These are sudden, involuntary “shocks” or muscle jerks. They can be triggered by sudden movements, light, or even loud noises. Note that individual jerks should not automatically trigger medication changes; they are not always epileptic seizures [1].
  • Seizures: Most patients develop at least one type of seizure. In the small case series, about 75% of cases had seizures that did not respond well to standard antiseizure medications [1].
  • Dyskinesia: In the same small series, about 77% of patients developed dyskinesia, which are uncontrolled, rhythmic, or flowing body movements that can interfere with walking or using the hands [1].

What to Expect as FENIB Progresses

The progression of FENIB involves an increasing need for support.

  1. Increased Seizure Frequency: Over time, seizures and muscle jerks may become more frequent and harder to manage with medication [1].
  2. Loss of Independence: As cognitive decline and movement issues worsen, daily tasks like dressing, eating, and bathing will require more assistance. In one documented case, a patient who started showing symptoms at age 11 required significant care by age 16 [1].
  3. End-Stage Decline: In the final stages, the damage to the brain’s neurons becomes widespread. This leads to severe dementia and physical frailty. Because the disease is so rare, your care team will provide palliative care—ensuring comfort, managing pain, and supporting your family through these transitions alongside active medical management [4].

While the lack of a cure is heavy, knowing the likely path allows you to prepare. Early conversations about care goals, home safety, and specialized neurology support can help you maintain your loved one’s quality of life for as long as possible.

Common questions in this guide

What are the earliest signs of FENIB?
In some people, FENIB first causes subtle changes in attention, planning, judgment, personality, or social behavior. Myoclonus or seizures may come first in others, so a new pattern of cognitive, behavioral, or movement symptoms should be discussed with a neurologist.
Can a SERPINI1 mutation predict when FENIB will begin?
The specific SERPINI1 variant can influence how unstable neuroserpin is and may affect age of onset and severity. G392E has been reported with childhood or adolescent onset, while S49P has been reported with later adult onset, but the available reports are very limited and cannot predict one person’s course.
How does FENIB progress over time?
FENIB may progress from behavioral or cognitive changes to more frequent myoclonus, seizures, dyskinesia, and worsening thinking or movement problems. As independence decreases, a person may need help with dressing, eating, bathing, communication, mobility, and safety; the pace varies widely.
Are all FENIB muscle jerks seizures?
No. Myoclonus is a sudden involuntary muscle jerk and may be triggered by movement, light, or sound, while an epileptic seizure reflects abnormal electrical activity in the brain. A clinician should assess the events before medication is changed, because an isolated jerk is not automatically a seizure.
What is the life expectancy for someone with FENIB?
A review of 13 documented cases reported a median age of symptom onset of about 21 years and a median age of death of about 33 years. These figures come from a very small, selected group and do not predict an individual’s life expectancy.
How is advanced FENIB managed?
There is currently no cure for FENIB, and seizures or myoclonus may become difficult to control with standard medicines. Neurology care, home-safety planning, monitoring for swallowing and gait problems, and palliative care can support comfort, safety, and family needs alongside active medical management.

Get notified when new evidence is published on Familial encephalopathy with neuroserpin inclusion bodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (4)
  1. 1

    Role of SERPINI1 pathogenic variants in familial encephalopathy with neuroserpin inclusion bodies: A case report and literature review.

    Yang X, Fang Z, Yan L, et al.

    Seizure 2022; (103()):137-147 doi:10.1016/j.seizure.2022.11.008.

    PMID: 36417830
  2. 2

    Progressive myoclonus epilepsy associated with neuroserpin inclusion bodies (neuroserpinosis).

    Roussel BD, Lomas DA, Crowther DC

    Epileptic disorders : international epilepsy journal with videotape 2016; (18(S2)):103-110 doi:10.1684/epd.2016.0847.

    PMID: 27618835
  3. 3

    Frontal deficits and atrophy in a patient with familial encephalopathy with neuroserpin inclusion bodies detected by single-case voxel-based morphometry: a case report.

    Handa H, Sugiyama A, Kaname T, et al.

    BMC neurology 2024; (24(1)):9 doi:10.1186/s12883-023-03511-0.

    PMID: 38166833
  4. 4

    An Inducible Neural Stem Progenitor Cell Model for Testing Therapeutic Interventions Against Neurodegeneration FENIB.

    Giustini A, Maiocchi A, Serangeli I, et al.

    Drug development research 2025; (86(1)):e70041 doi:10.1002/ddr.70041.

    PMID: 39749681

This page describes reported FENIB symptoms and progression for informational purposes only and does not constitute medical advice. Because FENIB is rare and courses vary, consult a neurologist and your care team about your family’s mutation, treatment, and support needs.